The Introduction of AI-Powered Chatbots in Pharmacy Practice

By HEOR Staff Writer

October 11, 2023

AI-powered Chatbots in Pharmacy Practice

The Encouraging Possibilities Offered by ChatGPT

The field of healthcare is one of the many industries that has been significantly advanced by the application of artificial intelligence (AI). A recent study sheds light on the potential of chatbots driven by artificial intelligence, notably ChatGPT, to revolutionise the practice of pharmacy. Patients can receive assistance from ChatGPT, a conversational bot, which responds to questions regarding their health and offers individualised guidance. The efficacy of this technology, on the other hand, is highly dependent on the level of expertise of the pharmacists who use it.

AI-powered Chatbots in Pharmacy Practice

According to the findings of the study, the majority of participants were aware of the possible advantages that ChatGPT could provide to the pharmaceutical industry. They were all in agreement that ChatGPT might be of tremendous use to pharmacists, particularly in terms of creating ideas connected to pharmaceutical marketing and offering educational information relating to pharmacy items or therapeutic areas.

Concerns Should Be Addressed and Use Made More Efficiently

While it is clear that ChatGPT may have some positive applications, the study also brought to light several possible drawbacks and concerns. These include the possibility of inaccuracies in the responses provided by ChatGPT, concerns regarding privacy brought on by the gathering and processing of data, and the possibility that AI systems will learn and reproduce prejudices based on the information they are trained on. These concerns highlight the necessity for careful implementation of AI systems, strict security measures, and regular monitoring.

Conclusion

A generally good impression of ChatGPT’s prospective function in the pharmaceutical sector was revealed by the findings of the study, notwithstanding the reservations that were raised. The findings imply that the issues can be minimized and the benefits of AI-powered chatbots can be improved in pharmacy practice through increased awareness, correct information, and user education.

Reference url

Recent Posts

EMA CHMP Meeting Highlights
Regulatory Insights from EMA CHMP Meeting Highlights

By HEOR Staff Writer

June 26, 2026

The EMA CHMP Meeting Highlights from 22-25 June 2026 show the committee advancing six new medicines while maintaining rigorous evidentiary standards for complex and rare conditions. Positive opinions covered an inactivated influenza vaccine for adults 50 and older, a levodopa-carbidopa intestinal...
KEYTRUDA combination therapy
KEYTRUDA Combination Therapy Gains FDA Approval for Advanced Triple-Negative Breast Cancer

By João L. Carapinha

June 26, 2026

The FDA has approved KEYTRUDA combination therapy with Trodelvy as first-line treatment for adults with unresectable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1 at a Combined Positive Score of 10 or greater. This marks the first regulatory nod for a PD-...
cemdisiran gMG treatment
Breakthrough in cemdisiran gMG treatment Advances Regulatory Landscape

By João L. Carapinha

June 25, 2026

Cemdisiran gMG treatment has cleared a critical hurdle after the FDA and EMA accepted Regeneron’s regulatory submissions for review in anti-AChR antibody-positive generalized myasthenia gravis (gMG). The investigational siRNA therapy targeting complement protein C5 could become the first subcutan...